Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.11 |
Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.62 |
Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.34 |
GAB1 signalosome | R-HSA-180292 | 6.31 |
Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.47 |
Signaling by EGFR | R-HSA-177929 | 4.59 |
TCR signaling | R-HSA-202403 | 6.64 |
TAK1 activates NFkB by phosphorylation and activation of IKKs complex | R-HSA-445989 | 8.08 |
RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 8.59 |
AKT phosphorylates targets in the cytosol | R-HSA-198323 | 9.28 |
Diseases of Immune System | R-HSA-5260271 | 8.34 |
Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.71 |
Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.51 |
Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.73 |
PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.37 |
DAP12 interactions | R-HSA-2172127 | 4.56 |
Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.71 |
Signaling by ERBB2 | R-HSA-1227986 | 4.66 |
FCERI mediated NF-kB activation | R-HSA-2871837 | 5.11 |
PI3K/AKT activation | R-HSA-198203 | 6.32 |
IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 8.46 |
Immune System | R-HSA-168256 | 2.37 |
PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.37 |
Downstream signal transduction | R-HSA-186763 | 4.65 |
Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 4.95 |
Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.73 |
MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.68 |
MyD88-independent TLR3/TLR4 cascade | R-HSA-166166 | 6.47 |
ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.28 |
Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.94 |
Interleukin-1 signaling | R-HSA-446652 | 7.52 |
Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.03 |
Innate Immune System | R-HSA-168249 | 3.17 |
Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 7.1 |
CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.38 |
Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.94 |
Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.71 |
NGF signalling via TRKA from the plasma membrane | R-HSA-187037 | 4.51 |
IKBKB deficiency causes SCID | R-HSA-5602636 | 11.4 |
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.72 |
PI3K events in ERBB4 signaling | R-HSA-1250342 | 6.37 |
MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.73 |
IkBA variant leads to EDA-ID | R-HSA-5603029 | 10.18 |
TRIF-mediated TLR3/TLR4 signaling | R-HSA-937061 | 6.47 |
Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.51 |
RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways | R-HSA-168928 | 6.7 |
Disease | R-HSA-1643685 | 3.33 |
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 9.18 |
IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 9.98 |
PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.37 |
PI-3K cascade:FGFR1 | R-HSA-5654689 | 6.37 |
Toll-Like Receptors Cascades | R-HSA-168898 | 5.91 |
Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.59 |
C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.06 |
Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.56 |
Downstream TCR signaling | R-HSA-202424 | 7.01 |
PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.56 |
Diseases of signal transduction | R-HSA-5663202 | 4.89 |
Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.68 |
NOD1/2 Signaling Pathway | R-HSA-168638 | 7.85 |
PI-3K cascade:FGFR2 | R-HSA-5654695 | 6.37 |
Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.71 |
Signaling by FGFR2 | R-HSA-5654738 | 4.68 |
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 7.31 |
MyD88:Mal cascade initiated on plasma membrane | R-HSA-166058 | 6.56 |
Signaling by FGFR1 | R-HSA-5654736 | 4.69 |
Signaling by PDGF | R-HSA-186797 | 4.53 |
Activated TLR4 signalling | R-HSA-166054 | 6.27 |
Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.62 |
Signaling by Interleukins | R-HSA-449147 | 4.71 |
Cytokine Signaling in Immune system | R-HSA-1280215 | 3.74 |
NIK--noncanonical NF-kB signaling | R-HSA-5676590 | 7.12 |
Signaling by ERBB4 | R-HSA-1236394 | 4.7 |
Adaptive Immune System | R-HSA-1280218 | 3.19 |
TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.4 |
PIP3 activates AKT signaling | R-HSA-1257604 | 6.37 |
Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 8.4 |
Signaling by FGFR4 | R-HSA-5654743 | 4.69 |
Signaling by FGFR3 | R-HSA-5654741 | 4.69 |
TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.4 |
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 9.4 |
Signaling by FGFR | R-HSA-190236 | 4.67 |
Signaling by SCF-KIT | R-HSA-1433557 | 4.73 |
DAP12 signaling | R-HSA-2424491 | 4.64 |
IRAK1 recruits IKK complex | R-HSA-937039 | 9.18 |
Signalling by NGF | R-HSA-166520 | 4.23 |
Signal Transduction | R-HSA-162582 | 1.78 |